Surgery and Interventional Science
Athena SWAN Bronze Award Logo


Division of Surgery Away Day 2014

Starts: Sep 18, 2014 9:00:00 AM



UCL Provost at Stanmore

UCL Provost visits Stanmore

The UCL President and Provost, Professor Michael Arthur, visited the Division’s Stanmore campus earlier this month, to meet staff and students from the Institute of Orthopaedics and Musculoskeletal Science (IOMS) and the Royal National Orthopaedic Hospital (RNOH).

Published: Jul 18, 2014 11:39:14 AM

Melissa Bovis @ Science Museum

Public Engagement: Building Bridges Project - Science Museum 2014

Having recently collaborated with the Science Museum in February this year where she hosted a Nanotechnology workshop at the Science Museum’s Lates event, Melissa Bovis, Research Associate, teamed up with the Museum for a second time this month as part of their Building Bridges scheme.  More...

Published: Jul 18, 2014 11:18:05 AM

Novel Randomised Trial in Prostate Cancer awarded St Peters Trust/Royal Free Charity grant

Over 40,000 men are diagnosed with prostate cancer every year in the UK. There is much uncertainty about which treatments might be best for these men, so Level I evidence is often required. Traditionally, Level I evidence comprises a head-to-head randomised controlled trial (RCT) of a new intervention versus placebo in which neither the patient nor the doctor knows who is taking what (‘double-blind’). The treatment allocation is based on chance and the blinding prevents biases. In surgery, this design is not always ethical or practical. This means that both doctor and patient have to be made aware of the treatment received in surgical trials. This causes problems. First, surgeons and patients often have strong - but sometimes misplaced - ideas of what works, so RCTs are difficult to recruit to. Second, this often means patients have to seek out trials, leading to a select group of motivated, commonly more educated and affluent patients participating in trials. Third, patients who take part in a trial may not approve of the treatment they have been allocated by chance and withdraw. These factors have led to the failure of many surgical trials to accrue. This has been particularly highlighted in localised prostate cancer RCTs. In fact, 11 RCTs evaluating different interventions in localised prostate in the last decade have failed to recruit.

Published: Jul 18, 2014 11:06:56 AM

Athena SWAN Bronze Award Logo

Division awarded Athena SWAN Bronze Award

The Division is delighted to announce that it has been awarded an Athena Swan Bronze Award for its efforts in supporting and empowering women within the Division.

Published: May 30, 2014 11:40:35 AM

Miss Clare Marx

President-Elect of Royal College of Surgeons to visit Division

Miss Clare Marx, Consultant Orthopaedic Surgeon and Associate Medical Director at Ipswich Hospital NHS Trust, will be speaking at the Division’s Academic Surgical Meeting in July. More...

Published: May 30, 2014 11:36:17 AM

Dr Kate Ricketts awarded funding from WTISSF & STFC

Dr Kate Ricketts, Lecturer in Cancer Nanotechnology, has been awarded a grant under the Wellcome Trust Institutional Strategic Fund-Investing in Excellent Researchers scheme as principal investigator for the use of nanoparticles as theranostic radiosensitisers. More...

Published: May 30, 2014 11:29:52 AM

Hashim Ahmed awarded funding from PCUK

Hashim Ahmed, Senior Clinical Lecturer and Honorary Consultant Urological Surgeon, has been awarded £171,000 from Prostate Cancer UK to test the hypothesis that multi-parametric ultrasound has the ability to detect and rule-out clinically significant prostate cancer as an alternative to biopsies. More...

Published: May 30, 2014 11:27:59 AM

Laurence Lovat

Staff Spotlight - Dr Laurence Lovat

This month, the spotlight is on Dr Laurence Lovat, Head of the Research Department of Tissue and Energy and Reader in Gastroenterology and Laser Medicine. More...

Published: May 30, 2014 11:09:38 AM

Logos Royal Free London - NHS Royal National Orthopaedic Hospital - NHS University College London Hospitals - NHS UCL Institute of Biomedical Engineering NPIMR